ALKERMES | ALKS - 時価総額





時価総額 変化する 日付
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
ALKERMES USD 7.93B 806M 2026-08
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Malin Corporation EUR 142.92M 19.65M 2026-02
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 13.12B 12.26B 2026-07
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Otsuka Holdings JPY 5.87T 111.31B 2026-06
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Vertex Pharmaceuticals USD 121.99B 8.4B 2026-08